Insider · CIK 0001863302
AI Day1 LLC
Files at DAWN (Day One Biopharmaceuticals, Inc.). First filing -, latest -.
AI Day1 LLC files SEC Form 4 as 10% owner at DAWN (Day One Biopharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; AI Day1 LLC has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | UTender of shares Common Stock | -12,929,322 | $21.50 | $278M | 0 | Apr 27, 2026 |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | DDisposition to issuer Pre-Funded Warrant (right to buy)derivative | -827,586 | $21.50 | $18M | 0 | Apr 27, 2026 |
Questions about AI Day1 LLC
Answered from the filings on this page, as of the latest one.
Is AI Day1 LLC buying or selling?
AI Day1 LLC has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did AI Day1 LLC's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and AI Day1 LLC has 0.
Where does AI Day1 LLC file Form 4?
AI Day1 LLC has filed Form 4 at DAWN (Day One Biopharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.